FrancophonIA/ELRC3.0 huggingface dataset:
English: What Viani looks like and contents of the pack Pressurised inhalation, suspension.
Estonian: Kuidas Viani välja näeb ja pakendi sisu
English: Patients should be made aware that Viani Evohaler must be used daily for optimum benefit, even when asymptomatic.
Estonian: Patsientidele tuleb selgitada, et parima terapeutilise toime saavutamiseks tuleb ravimit manustada regulaarselt, seda ka sümptomite puudumisel.
English: Hold the inhaler upright with your thumb on the base, below the mouthpiece.
Estonian: Hoidke inhalaatorit püstises asendis (pöial on inhalaatori põhjal huuliku all) ja hingake sügavalt välja.
English: The non-CFC propellant, Norflurane, has been shown to have no toxic effect at very high vapour concentrations, far in excess of those likely to be experienced by patients, in a wide range of animal species exposed daily for periods of two years.
Estonian: Kloorfluorsüsinikku (CFC) mittesisaldaval propellendil norfluraanil ei ole toksilist toimet ka väga suurte kontsentratsioonide puhul.
English: The initial starting dose is 2 inhalations of 25 mcg salmeterol and 50 mcg FP twice daily.
Estonian: Esialgseks algannuseks on 25 mcg salmeterooli ja 50 mcg flutikasoonpropionaadi kaks sissehingamist, kaks korda päevas.
English: To make sure that it works, shake the inhaler well and press the can to release puffs into the air until the counter reads 120.
Estonian: Inhalaatori kontrollimiseks loksutage seda korralikult ja pihustage paar ravimiannust õhku, kuni annuselugeja näit on 120.
English: Hold your breath, take the inhaler from your mouth and your finger from the top of the inhaler.
Estonian: Hoidke hinge kinni mõned sekundid või seni kuni on mugav ning samal ajal eemaldage huulik suust ja sõrm inhalaatorilt.
English: To remove the mouthpiece cover, hold the sides of the inhaler with your thumb and forefinger, squeeze the cover gently and pull apart.
Estonian: Katte eemaldamiseks vajutage ettevaatlikult pöidla ja nimetissõrmega selle külgedele ning seejärel tõmmake.
English: Viani is contraindicated in patients with hypersensitivity to any of the active substances or to the excipient.
Estonian: Ülitundlikkus toimeainete või ravimi ükskõik millise abiaine suhtes.
English: Remove the mouth piece cover.
Estonian: Eemaldage huuliku kate.
English: Place the mouthpiece in your mouth between your teeth and close your lips around it. Do not bite it.
Estonian: Asetage huulik huulte ja hammaste vahele.
English: Patients should never try to alter the numbers on the counter or detach the counter from the metal canister.
Estonian: Kunagi ei tohi proovida muuta annuselugeja näitu või annuselugejat konteineri küljest eemaldada, Annuselugejat ei saa nullida ja see ei ole konteineri küljest eemaldatav.
English: Luxembourg GlaxoSmithKline s.a./n.v.
Estonian: GlaxoSmithKline GmbH & Co.
English: Wipe the inside and outside of the mouthpiece and the plastic casing with a dry cloth or tissue.
Estonian: Pühkige kuiva lapi või pabersalvrätiga üle huuliku sise- ja välispind ning plastmassümbris.
English: Check inside and outside to make sure that the mouthpiece is clean and that there are no foreign objects.
Estonian: Kontrollige, kas huulik on seest- ja väljastpoolt puhas.
English: Cleaning your inhaler
Estonian: Inhalaatori puhastamine
English: The use of a spacer device with the inhaler in order to derive greater therapeutic benefit is recommended for patients (in particular young children) who have difficulty co-ordinating inhalation with actuation (see section 4.4 Special Warnings and Precautions for use)
Estonian: Kui inhalaatori käsitsemine ja samaaegne sissehingamine valmistab raskusi, on parema terapeutilise toime saavutamiseks soovitatav vahemahuti kasutamine (eriti väikestel lastel).
English: What Viani contains - The active substance(s) are 25 micrograms salmeterol (as xinafoate) and 50, 125 or 250
Estonian: - Toimeained on 25 mikrogrammi salmeterooli (salmeteroolksinafoaadina) ja 50, 125 või
English: 25 micrograms of salmeterol (as salmeterol xinafoate) and 50, 125 or 250 micrograms of fluticasone propionate (delivered from the valve).
Estonian: Üks annus sisaldab 25 µg salmeterooli (salmeteroolksinafoaadina) ja 50, 125 või 250 µg flutikasooni (flutikasoonpropionaadina).
English: - The other ingredient is Norflurane (HFA 134a).
Estonian: - Abiaine on norfluraan (HFA 134a).
English: If the inhaler has not been used for a week or more remove the mouthpiece cover, the patients should shake the inhaler well and release two puffs into the air. Each time the inhaler is activated the number on the counter will count down by one.
Estonian: Kui inhalaatorit ei ole kasutatud nädal aega või kauem, tuleb eemaldada huuliku kate, loksutada inhalaatorit korralikult ja pihustada kaks ravimiannust õhku.
English: The dose should be titrated to the lowest dose at which effective control of symptoms is maintained.
Estonian: Arst määrab teile väikseima toimiva annuse, mis tagab kontrolli haigusnähtude üle.
English: Increasing use of short-acting bronchodilators to relieve asthma symptoms indicates deterioration of asthma control and patients should be reviewed by a physician.
Estonian: Lühitoimeliste bronhodilataatorite annuse suurendamise vajadus ravi ajal näitab seisundi halvenemist.
English: - Replace the mouthpiece cover.
Estonian: - Asetage tagasi huuliku kate.
English: Medium dose ICS (>500-1000mcg BDP or equivalent/day)
Estonian: ICS ei kasutatud (ainult SABA) Väikeses annuses ICS (≤500 µg BDP või samaväärset päevas) Keskmises annuses ICS (>500-1000 µg BDP või samaväärset päevas) Ühendatud tulemused kolme ravitasandi lõikes
English: After use, always replace the mouthpiece cover immediately to keep out dust.
Estonian: Pärast inhalaatori kasutamist asetage alati tagasi huuliku kate, et kaitsta huulikut tolmu ja mustuse eest.
English: micrograms fluticasone propionate.
Estonian: 250 mikrogrammi flutikasoonpropionaati.
English: Possible systemic effects include Cushing's syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, decrease in bone mineral density, cataract and glaucoma.
Estonian: Võimalikud süsteemsed toimed on järgmised: neerupealiste supressioon, kasvupeetus lastel ja noorukitel, luu mineraalse tiheduse vähenemine, katarakt ja glaukoom.
English: Testing the inhaler:
Estonian: Inhalaatori kontroll:
English: Testing the inhaler
Estonian: Inhalaatori kontroll
English: Each puff provides 25 micrograms of salmeterol (as xinafoate) together with either 50, 125 or 250 micrograms of fluticasone propionate.
Estonian: Üks annus sisaldab toimeainetena 25 mikrogrammi salmeterooli (salmeteroolksinafoaadina) ja 50 mikrogrammi, 125 mikrogrammi või 250 mikrogrammi flutikasoonpropionaati.
English: Belgium GlaxoSmithKline s.a./n.v.
Estonian: Luksemburg GlaxoSmithKline s.a./n.v., Rue du Tilleul 13,
English: You should get a replacement when the counter shows the number 020.
Estonian: Kui annuselugeja näit on 020, tuleb hankida uus inhalaator.
English: Just after starting to breathe in through their mouth, patients should press down on the top of the inhaler to release Viani, while still breathing in steadily and deeply.
Estonian: Patsiendid peavad suu kaudu sügavalt ja ühtlaselt sisse hingama ning samal ajal vajutama ravimiannuse manustamiseks inhalaatorile.
English: STATEMENT OF ACTIVE SUBSTANCE(S) 25 micrograms of salmeterol (as xinafoate) and 50 micrograms of fluticasone propionate per actuation
Estonian: Üks annus sisaldab 25 mikrogrammi salmeterooli (salmeteroolksinafoaadina) ja 50 mikrogrammi flutikasoonpropionaati
English: STATEMENT OF ACTIVE SUBSTANCE(S) 25 micrograms of salmeterol (as xinafoate) and 125 micrograms of fluticasone propionate per actuation
Estonian: Üks annus sisaldab 25 mikrogrammi salmeterooli (salmeteroolksinafoaadina) ja 125 mikrogrammi flutikasoonpropionaati
English: CLINICAL PARTICULARS 4.1 Therapeutic indications Viani is indicated in the regular treatment of asthma where use of a combination product (long-acting beta-2-agonist and inhaled corticosteroid) is appropriate: patients not adequately controlled with inhaled corticosteroids and ‘as needed' inhaled short acting beta-2-agonist or patients already adequately controlled on both inhaled corticosteroid and long-acting beta-2-agonist.
Estonian: - inhaleeritavad glükokortikosteroidid ja „vastavalt vajadusele“ inhaleeritav lühitoimeline β2adrenomimeetikum ei taga piisavat kontrolli astmanähtude üle või - on juba saavutatud piisav kontroll inhaleeritava glükokortikosteroidi ja pikatoimelise β2adrenomimeetikumiga.
English: Just after starting to breathe in through your mouth, press down on the top of the can to release a puff while still breathing in steadily and deeply.
Estonian: Hingake suu kaudu sügavalt ja ühtlaselt sisse ning samal ajal vajutage ravimiannuse manustamiseks inhalaatorile.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Viani Evohaler and associated names (see Annex I) 25/125 microgram/dose pressurised inhalation, suspension [See Annex I - To be completed nationally]
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE(D) VIANI EVOHALER ja sarnased nimetused (vt lisa I), 25/125 mikrogrammi/annus, inhaleeritav aerosool, suspensioon [Vt lisa I - täidetakse riiklikult]
English: STATEMENT OF ACTIVE SUBSTANCE(S) 25 micrograms of salmeterol (as xinafoate) and 250 micrograms of fluticasone propionate per actuation
Estonian: Üks annus sisaldab 25 mikrogrammi salmeterooli (salmeteroolksinafoaadina) ja 250 mikrogrammi flutikasoonpropionaati
English: Two inhalations of 25 micrograms salmeterol and 250 micrograms fluticasone propionate twice daily.
Estonian: 2 x 25 µg salmeterooli ja 2 x 250 µg flutikasoonpropionaati kaks korda ööpäevas.
English: Viani Evohaler and associated names (see Annex I) 25/125 microgram/dose pressurised inhalation, suspension
Estonian: Viani Evohaler ja sarnased nimetused (vt lisa I), 25/125 mikrogrammi/annus, inhaleeritav aerosool, suspensioon
English: A short term trial of Viani may be considered as initial maintenance therapy in adults or adolescents with moderate persistent asthma (defined as patients with daily symptoms, daily rescue use and moderate to severe airflow limitation) for whom rapid control of asthma is essential.
Estonian: Mõõduka persisteeruva astmaga täiskasvanutel või noorukitel, kellel on oluline kiire astma kontrolli alla saamine, võib VIANI lühiajalist proovimist arvestada kui esialgset püsiravi.
English: Viani Evohaler and associated names (see Annex I) 25/125 microgram/dose pressurised inhalation, suspension [See Annex I - To be completed nationally]
Estonian: VIANI EVOHALER ja sarnased nimetused (vt lisa I), 25/125 mikrogrammi/annus, inhaleeritav aerosool, suspensioon [Vt lisa I - täidetakse riiklikult]
English: Shake the inhaler before use.
Estonian: Enne inhalaatori esmakordset kasutamist eemaldage inhalaatorilt huuliku kate.
English: Viani Evohaler and associated names (see Annex I) 25/50 microgram/dose pressurised inhalation, suspension
Estonian: Viani Evohaler ja sarnased nimetused (vt lisa I), 25/50 mikrogrammi/annus, inhaleeritav aerosool, suspensioon
English: Two inhalations of 25 micrograms salmeterol and 125 micrograms fluticasone propionate twice daily.
Estonian: 2 x 25 µg salmeterooli ja 2 x 125 µg flutikasoonpropionaati kaks korda ööpäevas või
English: The preferred antidotes are cardioselective beta-blocking agents, which should be used with caution in patients with a history of bronchospasm.
Estonian: Patsiendil, kellel on esinenud bronhospasmi, tuleb kardioselektiivsete β-adrenoblokaatoritega olla ettevaatlik.
English: Viani Evohaler and associated names (see Annex I) 25/250 microgram/dose pressurised inhalation, suspension [See Annex I - To be completed nationally]
Estonian: VIANI EVOHALER ja sarnased nimetused (vt lisa I), 25/250 mikrogrammi/annus, inhaleeritav aerosool, suspensioon [Vt lisa I - täidetakse riiklikult]
English: Viani Evohaler and associated names (see Annex I) 25/250 microgram/dose pressurised inhalation, suspension.
Estonian: VIANI EVOHALER ja sarnased nimetused (Vaata Lisa I), 25/250 µg inhaleeritav aerosool, suspensioon.
English: Viani Evohaler and associated names (see Annex I) 25/125 microgram/dose pressurised inhalation, suspension.
Estonian: VIANI EVOHALER ja sarnased nimetused (Vaata Lisa I), 25/125 µg inhaleeritav aerosool, suspensioon.
English: Viani Evohaler and associated names (see Annex I) 25/50 microgram/dose pressurised inhalation, suspension [See Annex I - To be completed nationally]
Estonian: VIANI EVOHALER ja sarnased nimetused (vt lisa I), 25/50 mikrogrammi/annus, inhaleeritav aerosool, suspensioon [Vt lisa I - täidetakse riiklikult]
English: GlaxoSmithKline GmbH & Co. KG Theresienhohe 11
Estonian: KG Theresienhohe 11
English: Both non-selective and selective beta-blockers should be avoided in patients with asthma, unless there are compelling reasons for their use.
Estonian: Hingamisteede pöörduva obstruktsiooni korral ei tohi määrata mitteselektiivseid ega selektiivseid β-adrenoblokaatoreid.
English: Viani Evohaler and associated names (see Annex I) 25/50 microgram/dose pressurised inhalation, suspension.
Estonian: VIANI EVOHALER ja sarnased nimetused (Vaata Lisa I), 25/50 µg inhaleeritav aerosool, suspensioon.
English: After use patients should always replace the mouthpiece cover by firmly pushing and snapping the cap into position.
Estonian: Pärast kasutamist tuleb alati tagasi asetada huuliku kate, liigset jõudu rakendamata.
English: Each time the can is pressed, a puff of medicine is released and the counter will count down by one.
Estonian: Iga annuse vabanemisel näitab annuselugeja ühe võrra väiksemat numbrit.
English: Two inhalations of 25 micrograms salmeterol and 50 micrograms fluticasone propionate twice daily.
Estonian: Üle 4-aastased lapsed: 25 µg salmeterooli ja 50 µg flutikasoonpropionaadi kaks inhalatsiooni kaks korda ööpäevas.
English: PHARMACEUTICAL FORM Pressurised inhalation, suspension.
Estonian: MANUSTAMISVIIS JA -TEE Loksutage inhalaatorit korralikult.
English: The study was completed on 31 July 2016.
Estonian: Uuring lõpetati 31. juulil 2016.
English: Dublin 2, Ireland Tel: +353 86 803 8014 info@retrophin.com
Estonian: Dublin 2, Iirimaa Tel.: +353 86 803 8014 info@retrophin.com
English: This medicine is intended for long-term use.
Estonian: See ravim on mõeldud pikaaegseks kasutamiseks.
English: Your doctor will tell you how many capsules you need to take, and when you should take the capsules.
Estonian: Teie arst ütleb teile mitu kapslit te peate võtma, ja millal te peate oma kapsleid võtma.
English: DATE OF FIRST AUTHORISATION 20 November 2015
Estonian: ESMASE MÜÜGILOA VÄLJASTAMISE KUUPÄEV 20. november 2015
English: Shellac (E904)
Estonian: Šellak (E904)
English: Once the bottle is opened, the medicinal product must be used within 3 months.
Estonian: Pärast pudeli avamist tuleb ravim ära kasutada 3 kuu jooksul.
English: The physician's educational material should contain the following key elements:
Estonian: Arstidele mõeldud koolitusmaterjal peab sisaldama järgmisi võtmeelemente:
English: There are several enzyme defects described in the literature.
Estonian: Kirjanduses on kirjeldatud mitut ensüümidefekti.
English: Do not take more capsules than your doctor has advised you.
Estonian: Ärge võtke rohkem kapsleid kui arst on teil soovitanud võtta.
English: In the event of overdose the patient should be monitored and treated symptomatically.
Estonian: Üleannustamise korral tuleb patsienti jälgida ja ravida sümptomaatiliselt.
English: The dose should be adjusted accordingly, as described above.
Estonian: Ravimi annust tuleb kohandada eespool kirjeldatud viisil.
English: Some of the primary defects include but are not limited to:
Estonian: Mõningad esmased defektid on muu hulgas:
English: A total of 85 patients took part in the clinical study.
Estonian: Kokku osales kliinilises uuringus 85 patsienti.
English: For additional information, see section 6.6.
Estonian: Lisateavet vt lõik 6.6.
English: It is recommended that cholic acid is taken with food (see section 4.5) at approximately the same time each day, in the morning and/or evening.
Estonian: Koolhapet on soovitatav võtta koos toiduga (vt lõik 4.5) iga päev umbes samal kellaajal, hommikuti ja/või õhtuti.
English: Other medicines and Kolbam
Estonian: Muud ravimid ja Kolbam
English: Your doctor will advise you to take cholic acid at least 5 hours before or after taking the other medicine.
Estonian: Teie arst soovitab teil võtta koolhapet vähemalt 5 tundi enne või pärast nende ravimite võtmist.
English: Side effects of unknown frequency (cannot be estimated from the available data):
Estonian: Teadmata esinemissagedusega kõrvaltoimed (esinemissagedust ei saa olemasolevate andmete alusel hinnata):
English: More frequent tests will be needed if you are growing fast, if you are ill (e.g., if you have liver problems) or if you are pregnant.
Estonian: Neid analüüse on vaja teha sagedamini ajal, kui te kasvate kiiresti, või kui te olete haige (nt kui teil on probleeme maksaga) või rase.
English: Patients should be monitored initially every 3 months during the first year then 6 monthly during the subsequent three years and annually thereafter.
Estonian: Patsiente jälgitakse esimesel raviaastal iga 3 kuu tagant, järgmise 3 aasta vältel iga 6 kuu tagant ja edasi kord aastas.
English: Your doctor will advise you if for any reason you have to stop treatment with cholic acid.
Estonian: Teie arst ütleb teile, kui te peate mingil põhjusel lõpetama ravi koolhappega.
English: The capsules contain a white powder.
Estonian: Kapslid sisaldavad valget pulbrit.
English: These are some of the medicines that may affect the way in which Kolbam works:
Estonian: Allpool on loetletud mõned ravimid, mis võivad mõjutada Kolbam'i toimet:
English: The mixture should be given immediately after preparation.
Estonian: Saadud segu tuleb manustada kohe pärast valmistamist.
English: Common side effects (may affect up to 1 in 10 people)
Estonian: Sageli esinevad kõrvaltoimed (võivad tekkida kuni 1 inimesel 10-st):
English: Swallow each capsule whole with water, either just before or just after food.
Estonian: Neelake kapslid tervelt koos veega, soovitatavalt kas kohe enne või kohe pärast sööki.
English: Patheon France 40 boulevard de champaret 38300 Bourgoin-Jallieu France
Estonian: Patheon France 40 boulevard de champaret 38300 Bourgoin-Jallieu Prantsusmaa
English: Kolbam can be used from the age of one month and patients affected by these conditions will need treatment for the rest of their life.
Estonian: Ravimit Kolbam võib kasutada alates 1 kuu vanusest ning nimetatud haigusseisunditega patsiendid vajavad seda ravi kogu ülejäänud elu vältel.
English: Should the use of a preparation containing one of these substances be necessary, it must be taken at least 5 hours before or after cholic acid.
Estonian: Kui nimetatud toimeaineid sisaldavate preparaatide kasutamine on vajalik, siis tuleb neid võtta vähemalt 5 tundi enne või pärast koolhapet.
English: Progress and results from the registry will form the basis of the annual reassessments of the benefit/risk profile of Kolbam.
Estonian: Registrisse kaasamise protsess ja registri tulemused on aluseks Kolbam'i kasu/riski profiili iga-aastastele taashindamistele.
English: On average, patients in this subgroup were 3 years at treatment start, minimum and maximum ages were 0 and 14 years, respectively.
Estonian: Keskmiselt olid patsiendid ravi alustamisel 3-aastased, maksimaalne ja minimaalne vanus oli vastavalt 0 ja 14 eluaastat.
English: • AMACR deficiency
Estonian: • AMACR-i puudulikkus;
English: Cholic acid also promotes normal growth of children.
Estonian: Koolhape soodustab samuti laste kasvu.
English: There is a theoretical possibility that administration of food may increase cholic acid bioavailability and improve tolerability.
Estonian: Esineb teoreetiline võimalus, et koos toiduga manustamine võib suurendada koolhappe biosaadavust ja parandada talutavust.
English: Patients that have previously been treated with other bile acids or other cholic acid preparations should be closely monitored in the same manner during the initiation of treatment with Kolbam.
Estonian: Patsiente, keda on varem ravitud teiste sapphapetega või teiste koolhappepreparaatidega, tuleb ravi alustamisel Kolbam'iga samamoodi tähelepanelikult jälgida.
English: The dose of cholic acid should be adjusted individually.
Estonian: Koolhappe annust tuleb individuaalselt kohandada.
English: Pharmacotherapeutic group: Bile and liver therapy, bile acid preparations; ATC code: A05AA03
Estonian: Farmakoterapeutiline rühm: sapiteede ja maksa ravi, sapphappepreparaadid, ATC-kood: A05AA03
English: The MAH shall ensure that at launch all physicians expected to prescribe the product are provided with information on the correct and safe use of the product.
Estonian: Müügiloa hoidja peab tagama, et ravimi turule toomisel saavad kõik arstid, kes eeldatavasti võiksid ravimit välja kirjutada, teabe ravimi õige ja ohutu kasutamise kohta.
English: The limited data from animal studies do not indicate direct reproductive toxicity (see section 5.3).
Estonian: Vähesed andmed loomkatsetest ei näita otsest reproduktiivset toksilisust (vt lõik 5.3).
English: • AMACR deficiency (n=1)
Estonian: • AMACR-i puudulikkus (n = 1);
English: - PSURs - Annual Reassessments
Estonian: - Perioodilised ohutusaruanded - Iga-aastased taashindamised
English: The effect of food on the bioavailability of cholic acid has not been studied.
Estonian: Toidu mõju koolhappe biosaadavusele ei ole uuritud.
English: • CYP7A1 deficiency
Estonian: • CYP7A1 puudulikkus.
English: To monitor the long term safety and efficacy in patients treated with Kolbam from a patient registry for which details are reflected in the risk management plan.
Estonian: Ravimiga Kolbam ravitud patsientide pikaajalise ohutuse ja efektiivsuse jälgimine patsientide registri alusel, mille üksikasjad on toodud riskijuhtimiskavas.
English: Prior to launch in each Member State, the MAH shall agree the final educational material with the competent authority in that Member State.
Estonian: Enne ravimi turule toomist igas liikmesriigis kooskõlastab müügiloa hoidja vastava liikmesriigi pädeva asutusega lõpliku koolitusmaterjali.
English: Store in original package in order to protect from light.
Estonian: Hoida originaalpakendis, et kaitsta valguse eest.
English: No formal preclinical safety studies have been conducted; however, data in the literature reveal no special hazard for humans based on studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction.
Estonian: Formaalseid prekliinilise ohutuse uuringuid ei ole läbi viidud, ent kirjandusandmed ei viita farmakoloogilise ohutuse, korduvtoksilisuse, genotoksilisuse, kartsinogeensuse, reproduktsiooni- ja arengutoksilisuse mittekliiniliste uuringute alusel kahjulikele toimetele inimesele.
English: In Study CAC-002-01, the mean age of patients at baseline was 9.0 years, with ages ranging from 0.1 to 35.6 years.
Estonian: Uuringus CAC-002-01 oli patsientide keskmine vanus algtasemel 9,0 aastat, ulatudes 0,1…35,6 aastani.
English: Cholic acid is one of the primary bile acids in man on which essential physiological functions depend.
Estonian: Koolhappe on inimesel üheks esmaseks sapphappeks, millest sõltuvad mitmed füsioloogilised funktsioonid.
English: SPECIAL STORAGE CONDITIONS Do not store above 30°C.
Estonian: SÄILITAMISE ERITINGIMUSED Hoida temperatuuril kuni 30 ºC.
English: Episodes of symptomatic overdose (or excessive dosing regimen) have been reported, including accidental overdose.
Estonian: Registreeritud on sümptomaatilise üleannustamise (või liiga suurte annuste kasutamise) episoode, sealhulgas juhusliku üleannustamise juhtum.
English: Do not store above 30 °C.
Estonian: Hoida temperatuuril kuni 30 ºC.
English: 90 capsules.
Estonian: 90 kapslit.
English: During your treatment, your doctor will carry out various blood and urine tests at different times to see how your body is handling this medicine and to help work out the dose that you need.
Estonian: Ravi ajal teeb arst erinevatel aegadel vere- ja uriinianalüüse, et näha kuidas teie organism antud ravimit omastab ja selleks, et määrata teile vajalik annus.